1. Home
  2. INLX vs ANTX Comparison

INLX vs ANTX Comparison

Compare INLX & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellinetics Inc.

INLX

Intellinetics Inc.

HOLD

Current Price

$7.67

Market Cap

35.9M

Sector

Technology

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

N/A

Current Price

$5.09

Market Cap

36.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INLX
ANTX
Founded
1996
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.9M
36.7M
IPO Year
2013
2022

Fundamental Metrics

Financial Performance
Metric
INLX
ANTX
Price
$7.67
$5.09
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
888.0
3.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.23
EPS
N/A
N/A
Revenue
$11,336.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$15.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.50
$1.00
52 Week High
$15.72
$6.91

Technical Indicators

Market Signals
Indicator
INLX
ANTX
Relative Strength Index (RSI) 42.50 87.89
Support Level $7.50 $1.05
Resistance Level $8.29 N/A
Average True Range (ATR) 0.06 0.55
MACD -0.02 0.47
Stochastic Oscillator 25.00 65.45

Price Performance

Historical Comparison
INLX
ANTX

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Share on Social Networks: